Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy S Breekveldt

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|December 16, 2004
Persistence with antihypertensives related to formulation: the case of nifedipineNancy S Breekveldt-Postma, Ron M C Herings
Respiratory Medicine|March 21, 2007
Enhanced persistence with tiotropium compared with other respiratory drugs in COPDNancy S Breekveldt-Postma, Jeroen Koerselman, Joëlle A Erkens, et al.
Pharmacoepidemiology and Drug Safety|October 28, 2004
Selective prescribing of atypical antipsychoticsNancy S Breekveldt-Postma, Igor Schillevoort, Willem A Nolen, et al.
Vascular Health and Risk Management|January 19, 2008
Higher persistence with valsartan compared with enalapril in daily practiceSatu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, et al.
Drug Discovery Today|November 28, 2015
Drug regulators and ethics: which GCP issues are also ethical issues?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Pharmacoepidemiology and Drug Safety|January 22, 2008
Treatment with inhaled corticosteroids in asthma is too often discontinuedNancy S Breekveldt-Postma, Jeroen Koerselman, Joëlle A Erkens, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control studyWim G Goettsch, Guido van den Boom, Nancy S Breekveldt-Postma, et al.
BMC Medical Ethics|October 28, 2020
Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Drug Discovery Today|July 10, 2019
Regulatory sanctions for ethically relevant GCP violationsRosemarie de la Cruz Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Current Medical Research and Opinion|February 20, 2008
Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO studyNancy S Breekveldt-Postma, Joëlle A Erkens, René Aalbers, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|December 16, 2004
Persistence with antihypertensives related to formulation: the case of nifedipineNancy S Breekveldt-Postma, Ron M C Herings
Respiratory Medicine|March 21, 2007
Enhanced persistence with tiotropium compared with other respiratory drugs in COPDNancy S Breekveldt-Postma, Jeroen Koerselman, Joëlle A Erkens, et al.
Pharmacoepidemiology and Drug Safety|October 28, 2004
Selective prescribing of atypical antipsychoticsNancy S Breekveldt-Postma, Igor Schillevoort, Willem A Nolen, et al.
Vascular Health and Risk Management|January 19, 2008
Higher persistence with valsartan compared with enalapril in daily practiceSatu J Siiskonen, Nancy S Breekveldt-Postma, Gábor Vincze, et al.
Drug Discovery Today|November 28, 2015
Drug regulators and ethics: which GCP issues are also ethical issues?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Pharmacoepidemiology and Drug Safety|January 22, 2008
Treatment with inhaled corticosteroids in asthma is too often discontinuedNancy S Breekveldt-Postma, Jeroen Koerselman, Joëlle A Erkens, et al.
Pharmacoepidemiology and Drug Safety|September 24, 2004
Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control studyWim G Goettsch, Guido van den Boom, Nancy S Breekveldt-Postma, et al.
BMC Medical Ethics|October 28, 2020
Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?Rosemarie D L C Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Drug Discovery Today|July 10, 2019
Regulatory sanctions for ethically relevant GCP violationsRosemarie de la Cruz Bernabe, Ghislaine J M W van Thiel, Nancy S Breekveldt, et al.
Current Medical Research and Opinion|February 20, 2008
Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO studyNancy S Breekveldt-Postma, Joëlle A Erkens, René Aalbers, et al.
Pageof 2